Healthcare Sector Stocks
The Healthcare sector has a total of 1052 stocks, with a combined market cap of $9.01 trillion, total revenue of $4.59 trillion and a weighted average PE ratio of 44.87.
Market Cap
9.01T
Revenue
4.59T
Profits
200.91B
PE Ratio
44.87
Profit Margin
4.38%
Dividend Yield
0.40%
1053 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | LLY | Eli Lilly and Company | 1.07T | 0.86% | 1,983,174 | 72.25B |
| 2 | JNJ | Johnson & Johnson | 634.77B | 1.59% | 6,350,944 | 97.93B |
| 3 | ABBV | AbbVie Inc. | 458.24B | 0.95% | 4,195,439 | 62.82B |
| 4 | UNH | UnitedHealth Group Incorporated | 382.09B | -0.67% | 3,752,476 | 450.13B |
| 5 | MRK | Merck & Co., Inc. | 323.72B | 0.45% | 6,154,296 | 65.77B |
| 6 | NVS | Novartis AG | 295.30B | -0.72% | 1,826,640 | 56.69B |
| 7 | AZN | AstraZeneca PLC | 262.19B | 0.59% | 2,009,474 | 60.44B |
| 8 | NVO | Novo Nordisk A/S | 215.94B | 1.22% | 10,799,111 | 50.57B |
| 9 | TMO | Thermo Fisher Scientific Inc. | 211.18B | -0.71% | 2,939,446 | 46.34B |
| 10 | AMGN | Amgen Inc. | 202.95B | 1.22% | 2,493,903 | 37.22B |
| 11 | ABT | Abbott Laboratories | 179.51B | 2.29% | 10,367,057 | 46.59B |
| 12 | GILD | Gilead Sciences, Inc. | 160.55B | -1.18% | 5,529,518 | 29.74B |
| 13 | PFE | Pfizer Inc. | 139.86B | -0.16% | 28,905,660 | 63.32B |
| 14 | CVS | CVS Health Corporation | 137.47B | 0.80% | 5,370,074 | 405.62B |
| 15 | DHR | Danaher Corporation | 134.62B | -0.52% | 6,849,447 | 25.11B |
| 16 | BMY | Bristol-Myers Squibb Company | 126.79B | 0.94% | 12,071,261 | 48.48B |
| 17 | SYK | Stryker Corporation | 126.60B | 3.54% | 2,372,732 | 25.27B |
| 18 | VRTX | Vertex Pharmaceuticals Incorporated | 121.16B | 0.90% | 1,252,858 | 12.22B |
| 19 | ISRG | Intuitive Surgical, Inc. | 119.23B | 1.65% | 3,438,606 | 11.03B |
| 20 | MDT | Medtronic plc | 106.51B | 1.46% | 4,336,131 | 36.36B |
| 21 | SNY | Sanofi | 104.06B | -0.02% | 3,067,591 | 54.60B |
| 22 | GSK | GSK plc | 101.99B | 1.20% | 5,963,357 | 43.29B |
| 23 | MCK | McKesson Corporation | 98.45B | 1.99% | 823,781 | 403.43B |
| 24 | HCA | HCA Healthcare, Inc. | 84.78B | 1.51% | 2,703,467 | 78.01B |
| 25 | ELV | Elevance Health, Inc. | 81.91B | -0.43% | 969,555 | 201.11B |
| 26 | CI | The Cigna Group | 76.60B | 1.15% | 1,084,217 | 277.89B |
| 27 | REGN | Regeneron Pharmaceuticals, Inc. | 66.74B | 0.63% | 708,346 | 14.92B |
| 28 | BSX | Boston Scientific Corporation | 65.77B | 1.54% | 20,689,853 | 20.61B |
| 29 | COR | Cencora, Inc. | 60.29B | 1.58% | 852,415 | 328.68B |
| 30 | ARGX | argenx SE | 57.28B | -0.69% | 324,066 | 5.32B |
| 31 | TAK | Takeda Pharmaceutical Company Limited | 55.09B | 2.50% | 3,266,528 | 28.34B |
| 32 | CAH | Cardinal Health, Inc. | 53.41B | 0.91% | 1,466,729 | 250.74B |
| 33 | MDLN | Medline Inc. | 50.91B | 2.98% | 5,000,686 | 29.14B |
| 34 | EW | Edwards Lifesciences Corporation | 47.58B | -1.42% | 10,517,525 | 6.51B |
| 35 | HUM | Humana Inc. | 46.74B | -1.31% | 740,261 | 137.20B |
| 36 | BDX | Becton, Dickinson and Company | 43.08B | 2.22% | 1,115,714 | 22.23B |
| 37 | IDXX | IDEXX Laboratories, Inc. | 42.94B | 0.92% | 437,283 | 4.45B |
| 38 | HLN | Haleon plc | 42.72B | 0.72% | 11,498,047 | 14.85B |
| 39 | RVMD | Revolution Medicines, Inc. | 40.23B | 0.25% | 1,288,030 | - |
| 40 | A | Agilent Technologies, Inc. | 39.14B | -0.84% | 1,516,451 | 7.23B |
| 41 | NTRA | Natera, Inc. | 37.52B | -1.02% | 699,314 | 2.50B |
| 42 | WAT | Waters Corporation | 36.79B | -2.02% | 819,189 | 3.77B |
| 43 | ALNY | Alnylam Pharmaceuticals, Inc. | 36.28B | 1.13% | 1,150,933 | 4.29B |
| 44 | ONC | BeOne Medicines AG | 36.23B | -0.27% | 346,473 | 5.74B |
| 45 | TEVA | Teva Pharmaceutical Industries Limited | 35.88B | -1.19% | 3,132,654 | 17.35B |
| 46 | IQV | IQVIA Holdings Inc. | 34.72B | 0.35% | 1,089,778 | 16.63B |
| 47 | RPRX | Royalty Pharma plc | 33.88B | -0.32% | 2,114,314 | 2.44B |
| 48 | ALC | Alcon Inc. | 33.28B | 1.04% | 1,256,846 | 10.63B |
| 49 | ZTS | Zoetis Inc. | 31.59B | 1.05% | 5,198,136 | 9.53B |
| 50 | CNC | Centene Corporation | 31.31B | -0.52% | 2,809,130 | 178.33B |
| 51 | VEEV | Veeva Systems Inc. | 30.25B | 3.71% | 1,056,801 | 3.32B |
| 52 | BIIB | Biogen Inc. | 29.85B | 0.78% | 596,256 | 9.94B |
| 53 | ILMN | Illumina, Inc. | 29.37B | -1.41% | 1,300,910 | 4.39B |
| 54 | RMD | ResMed Inc. | 28.17B | 1.76% | 1,005,229 | 5.54B |
| 55 | DXCM | DexCom, Inc. | 27.61B | 1.50% | 2,844,285 | 4.82B |
| 56 | GEHC | GE HealthCare Technologies Inc. | 27.56B | -2.22% | 9,134,013 | 20.98B |
| 57 | MTD | Mettler-Toledo International Inc. | 26.82B | -0.35% | 187,720 | 4.09B |
| 58 | PHG | Koninklijke Philips N.V. | 25.61B | 0.54% | 827,708 | 20.34B |
| 59 | ROIV | Roivant Sciences Ltd. | 25.18B | -0.26% | 4,043,202 | 8.26M |
| 60 | DGX | Quest Diagnostics Incorporated | 25.15B | -0.02% | 1,542,111 | 11.56B |
| 61 | LH | Labcorp Holdings Inc. | 24.34B | 1.98% | 916,281 | 14.14B |
| 62 | INCY | Incyte Corporation | 23.51B | 0.84% | 1,207,106 | 5.36B |
| 63 | INSM | Insmed Incorporated | 23.18B | -0.46% | 1,908,229 | 819.56M |
| 64 | WST | West Pharmaceutical Services, Inc. | 23.10B | -7.67% | 1,508,636 | 3.33B |
| 65 | BNTX | BioNTech SE | 22.59B | -2.97% | 886,018 | 3.23B |
| 66 | UTHR | United Therapeutics Corporation | 22.43B | -0.20% | 313,056 | 3.17B |
| 67 | MRNA | Moderna, Inc. | 21.45B | -5.17% | 4,427,773 | 2.23B |
| 68 | STE | STERIS plc | 20.86B | 1.63% | 511,416 | 5.94B |
| 69 | THC | Tenet Healthcare Corporation | 20.09B | 17.17% | 4,639,504 | 21.81B |
| 70 | VTRS | Viatris Inc. | 20.08B | -0.23% | 7,358,112 | 14.56B |
| 71 | GH | Guardant Health, Inc. | 19.54B | -1.91% | 1,884,831 | 1.08B |
| 72 | NBIX | Neurocrine Biosciences, Inc. | 17.67B | 0.93% | 1,129,494 | 3.10B |
| 73 | ZBH | Zimmer Biomet Holdings, Inc. | 17.67B | 1.90% | 1,251,898 | 8.41B |
| 74 | GMAB | Genmab A/S | 17.56B | -1.03% | 1,676,218 | 3.90B |
| 75 | MEDP | Medpace Holdings, Inc. | 16.79B | -0.73% | 492,279 | 2.78B |
| 76 | ASND | Ascendis Pharma A/S | 16.74B | 0.47% | 390,363 | 998.25M |
| 77 | BBIO | BridgeBio Pharma, Inc. | 16.47B | 1.31% | 2,058,261 | 579.96M |
| 78 | JAZZ | Jazz Pharmaceuticals plc | 15.95B | -0.39% | 538,211 | 4.44B |
| 79 | BTSG | BrightSpring Health Services, Inc. | 15.19B | 4.40% | 2,481,916 | 13.65B |
| 80 | DVA | DaVita Inc. | 15.12B | 0.50% | 535,281 | 13.84B |
| 81 | EXEL | Exelixis, Inc. | 13.92B | -0.50% | 1,837,908 | 2.38B |
| 82 | COO | The Cooper Companies, Inc. | 13.71B | 0.11% | 1,466,611 | 4.23B |
| 83 | SOLV | Solventum Corporation | 13.51B | 1.00% | 636,609 | 8.26B |
| 84 | FMS | Fresenius Medical Care AG | 13.07B | 0.61% | 650,417 | 22.32B |
| 85 | SNN | Smith & Nephew plc | 12.79B | 2.69% | 1,216,505 | 6.16B |
| 86 | ICLR | ICON Public Limited Company | 12.70B | -2.68% | 757,704 | 8.27B |
| 87 | MDGL | Madrigal Pharmaceuticals, Inc. | 12.55B | 0.21% | 147,385 | 1.13B |
| 88 | PEN | Penumbra, Inc. | 12.54B | 0.26% | 364,537 | 1.45B |
| 89 | ELAN | Elanco Animal Health Incorporated | 12.44B | 0.52% | 4,076,189 | 4.89B |
| 90 | AXSM | Axsome Therapeutics, Inc. | 12.40B | -0.22% | 461,840 | 708.24M |
| 91 | RVTY | Revvity, Inc. | 12.32B | -2.39% | 1,117,827 | 2.90B |
| 92 | ARWR | Arrowhead Pharmaceuticals, Inc. | 12.06B | -1.36% | 1,825,094 | 622.01M |
| 93 | ALGN | Align Technology, Inc. | 11.96B | -0.73% | 845,770 | 4.10B |
| 94 | BAX | Baxter International Inc. | 11.57B | 3.37% | 4,982,938 | 11.32B |
| 95 | BMRN | BioMarin Pharmaceutical Inc. | 11.47B | 0.78% | 1,937,645 | 3.24B |
| 96 | PODD | Insulet Corporation | 11.31B | 3.08% | 1,147,729 | 2.90B |
| 97 | EHC | Encompass Health Corporation | 11.20B | 1.65% | 816,656 | 6.07B |
| 98 | TECH | Bio-Techne Corporation | 11.16B | -0.24% | 2,061,615 | 1.21B |
| 99 | ABVX | ABIVAX Société Anonyme | 11.07B | -4.16% | 950,959 | 5.67M |
| 100 | CYTK | Cytokinetics, Incorporated | 10.96B | -1.44% | 1,848,760 | 105.82M |
| 101 | CRL | Charles River Laboratories International, Inc. | 10.91B | -1.18% | 476,147 | 4.03B |
| 102 | SMMT | Summit Therapeutics Inc. | 10.90B | -8.81% | 8,153,726 | - |
| 103 | GMED | Globus Medical, Inc. | 10.38B | 1.42% | 1,707,084 | 3.10B |
| 104 | MOH | Molina Healthcare, Inc. | 10.29B | -1.37% | 1,342,312 | 42.47B |
| 105 | CORT | Corcept Therapeutics Incorporated | 10.24B | -1.34% | 1,003,970 | 769.10M |
| 106 | APGE | Apogee Therapeutics, Inc. | 10.08B | 0.01% | 558,218 | - |
| 107 | ENSG | The Ensign Group, Inc. | 10.03B | 3.27% | 437,340 | 5.27B |
| 108 | RDY | Dr. Reddy's Laboratories Limited | 9.97B | 0.46% | 3,229,620 | 3.50B |
| 109 | KRYS | Krystal Biotech, Inc. | 9.88B | 2.35% | 520,338 | 417.30M |
| 110 | HSIC | Henry Schein, Inc. | 9.74B | 1.11% | 1,481,083 | 13.38B |
| 111 | HALO | Halozyme Therapeutics, Inc. | 9.72B | 1.35% | 1,661,094 | 1.51B |
| 112 | UHS | Universal Health Services, Inc. | 9.43B | 2.96% | 1,602,591 | 17.76B |
| 113 | IONS | Ionis Pharmaceuticals, Inc. | 9.35B | 1.22% | 3,094,732 | 1.06B |
| 114 | BRKR | Bruker Corporation | 9.20B | -2.74% | 1,243,919 | 3.46B |
| 115 | KYMR | Kymera Therapeutics, Inc. | 9.10B | 0.17% | 585,216 | 51.48M |
| 116 | PRAX | Praxis Precision Medicines, Inc. | 9.07B | 0.90% | 282,678 | 7.46M |
| 117 | GKOS | Glaukos Corporation | 9.02B | 0.95% | 379,547 | 551.35M |
| 118 | SYRE | Spyre Therapeutics, Inc. | 8.98B | 2.14% | 810,830 | - |
| 119 | CRNX | Crinetics Pharmaceuticals, Inc. | 8.83B | 0.10% | 2,344,320 | 18.07M |
| 120 | ALKS | Alkermes plc | 8.82B | -0.15% | 1,288,498 | 1.56B |
| 121 | PTGX | Protagonist Therapeutics, Inc. | 8.75B | 0.50% | 298,401 | 74.06M |
| 122 | QGEN | Qiagen N.V. | 8.56B | -0.19% | 1,835,108 | 2.10B |
| 123 | OSCR | Oscar Health, Inc. | 8.49B | -2.52% | 3,268,389 | 13.30B |
| 124 | ATR | AptarGroup, Inc. | 8.45B | 2.60% | 335,921 | 3.87B |
| 125 | BIO | Bio-Rad Laboratories, Inc. | 8.42B | -0.61% | 355,485 | 2.59B |
| 126 | IMVT | Immunovant, Inc. | 8.13B | 0.10% | 727,071 | - |
| 127 | TGTX | TG Therapeutics, Inc. | 7.94B | 0.97% | 1,431,807 | 700.35M |
| 128 | HQY | HealthEquity, Inc. | 7.91B | 0.32% | 973,767 | 1.34B |
| 129 | PCVX | Vaxcyte, Inc. | 7.89B | -1.76% | 1,120,739 | - |
| 130 | AVTR | Avantor, Inc. | 7.81B | 0.79% | 12,278,626 | 6.55B |
| 131 | TEM | Tempus AI, Inc. | 7.69B | -7.22% | 5,762,274 | 1.36B |
| 132 | LQDA | Liquidia Corporation | 7.67B | -3.16% | 1,592,106 | 288.07M |
| 133 | RGEN | Repligen Corporation | 7.45B | -4.10% | 1,359,901 | 763.34M |
| 134 | IBRX | ImmunityBio, Inc. | 7.44B | -4.05% | 8,524,632 | 140.98M |
| 135 | PACS | PACS Group, Inc. | 7.42B | 4.53% | 856,441 | 5.43B |
| 136 | RYTM | Rhythm Pharmaceuticals, Inc. | 7.00B | -0.55% | 467,132 | 217.17M |
| 137 | MIRM | Mirum Pharmaceuticals, Inc. | 6.89B | -1.16% | 516,939 | 569.61M |
| 138 | LNTH | Lantheus Holdings, Inc. | 6.82B | 1.05% | 474,086 | 1.55B |
| 139 | COGT | Cogent Biosciences, Inc. | 6.80B | -1.19% | 1,593,418 | - |
| 140 | CHE | Chemed Corporation | 6.76B | 1.61% | 113,905 | 2.54B |
| 141 | ERAS | Erasca, Inc. | 6.63B | -1.19% | 3,176,641 | - |
| 142 | GRFS | Grifols, S.A. | 6.62B | 0.53% | 3,092,200 | 8.58B |
| 143 | HIMS | Hims & Hers Health, Inc. | 6.50B | -14.20% | 28,490,195 | 2.37B |
| 144 | PTCT | PTC Therapeutics, Inc. | 6.37B | -2.08% | 838,163 | 827.11M |
| 145 | XENE | Xenon Pharmaceuticals Inc. | 6.32B | - | 528,927 | 7.50M |
| 146 | CGON | CG Oncology, Inc. | 6.11B | -2.53% | 368,758 | 5.07M |
| 147 | BLTE | Belite Bio, Inc | 6.03B | -1.87% | 172,383 | - |
| 148 | LGND | Ligand Pharmaceuticals Incorporated | 5.95B | -0.54% | 277,027 | 274.48M |
| 149 | TXG | 10x Genomics, Inc. | 5.87B | -3.72% | 2,667,944 | 638.78M |
| 150 | TFX | Teleflex Incorporated | 5.85B | 0.72% | 514,544 | 2.13B |
| 151 | BLLN | BillionToOne, Inc. | 5.80B | -2.22% | 479,105 | 354.54M |
| 152 | BLCO | Bausch + Lomb Corporation | 5.77B | 1.19% | 563,839 | 5.21B |
| 153 | HNGE | Hinge Health, Inc. | 5.75B | -3.10% | 1,516,536 | 646.34M |
| 154 | DFTX | Definium Therapeutics, Inc. | 5.73B | 0.56% | 1,118,179 | - |
| 155 | AMRX | Amneal Pharmaceuticals, Inc. | 5.72B | -0.28% | 1,156,440 | 3.05B |
| 156 | SRRK | Scholar Rock Holding Corporation | 5.71B | -3.66% | 838,668 | - |
| 157 | DNTH | Dianthus Therapeutics, Inc. | 5.68B | -0.88% | 827,623 | 1.34M |
| 158 | TWST | Twist Bioscience Corporation | 5.62B | -2.35% | 1,044,783 | 409.48M |
| 159 | ORKA | Oruka Therapeutics, Inc. | 5.56B | 0.23% | 579,221 | - |
| 160 | STVN | Stevanato Group S.p.A. | 5.37B | 1.44% | 336,366 | 1.39B |
| 161 | TVTX | Travere Therapeutics, Inc. | 5.33B | 1.20% | 1,228,530 | 536.20M |
| 162 | SHC | Sotera Health Company | 4.95B | -0.80% | 2,426,484 | 1.19B |
| 163 | INDV | Indivior Pharmaceuticals, Inc. | 4.94B | 0.04% | 837,609 | 1.29B |
| 164 | RDNT | RadNet, Inc. | 4.84B | 0.97% | 605,344 | 2.14B |
| 165 | KNSA | Kiniksa Pharmaceuticals International, plc | 4.83B | -0.33% | 619,928 | 754.05M |
| 166 | MMED | MiniMed Group, Inc. | 4.73B | 3.06% | 1,102,859 | 3.10B |
| 167 | CRSP | CRISPR Therapeutics AG | 4.58B | -2.08% | 1,419,474 | 4.10M |
| 168 | MANE | Veradermics, Incorporated | 4.58B | -5.48% | 533,152 | - |
| 169 | DYN | Dyne Therapeutics, Inc. | 4.56B | 2.30% | 5,066,096 | - |
| 170 | VCYT | Veracyte, Inc. | 4.52B | -2.19% | 589,698 | 541.74M |
| 171 | MMSI | Merit Medical Systems, Inc. | 4.43B | 1.66% | 655,224 | 1.54B |
| 172 | EWTX | Edgewise Therapeutics, Inc. | 4.39B | 3.95% | 1,027,994 | - |
| 173 | CAI | Caris Life Sciences, Inc. | 4.39B | -0.83% | 4,932,090 | 907.29M |
| 174 | WAY | Waystar Holding Corp. | 4.32B | 4.31% | 2,169,069 | 1.16B |
| 175 | LEGN | Legend Biotech Corporation | 4.30B | -5.57% | 1,693,895 | 1.14B |
| 176 | LIVN | LivaNova PLC | 4.30B | -0.53% | 412,287 | 1.43B |
| 177 | NVST | Envista Holdings Corporation | 4.28B | 0.61% | 1,864,587 | 2.81B |
| 178 | ACAD | ACADIA Pharmaceuticals Inc. | 4.25B | 0.04% | 1,046,975 | 1.10B |
| 179 | LFST | LifeStance Health Group, Inc. | 4.23B | 0.83% | 1,842,013 | 1.49B |
| 180 | CON | Concentra Group Holdings Parent, Inc. | 4.04B | 0.25% | 1,254,233 | 2.23B |
| 181 | VKTX | Viking Therapeutics, Inc. | 4.04B | -1.70% | 1,837,541 | - |
| 182 | CELC | Celcuity Inc. | 4.03B | -6.47% | 1,294,424 | - |
| 183 | RLAY | Relay Therapeutics, Inc. | 4.02B | -3.40% | 2,039,927 | 10.68M |
| 184 | ALHC | Alignment Healthcare, Inc. | 4.02B | -2.85% | 2,890,786 | 4.26B |
| 185 | PBLS | Parabilis Medicines, Inc. | 3.98B | -4.66% | 349,542 | - |
| 186 | ICUI | ICU Medical, Inc. | 3.93B | 2.59% | 258,588 | 2.16B |
| 187 | TNGX | Tango Therapeutics, Inc. | 3.85B | -2.99% | 2,461,337 | 56.99M |
| 188 | ELVN | Enliven Therapeutics, Inc. | 3.70B | 0.27% | 368,754 | - |
| 189 | DOCS | Doximity, Inc. | 3.67B | -0.15% | 2,181,148 | 644.86M |
| 190 | DNLI | Denali Therapeutics Inc. | 3.67B | -1.32% | 1,162,860 | - |
| 191 | BKD | Brookdale Senior Living Inc. | 3.62B | 4.48% | 5,076,958 | 3.00B |
| 192 | IRTC | iRhythm Holdings, Inc. | 3.59B | 1.42% | 317,845 | 787.85M |
| 193 | HAE | Haemonetics Corporation | 3.58B | 1.78% | 462,739 | 1.33B |
| 194 | RCUS | Arcus Biosciences, Inc. | 3.57B | -4.41% | 1,230,517 | 236.00M |
| 195 | ALMS | Alumis Inc. | 3.57B | -1.06% | 1,164,912 | 8.40M |
| 196 | ADPT | Adaptive Biotechnologies Corporation | 3.56B | -0.18% | 2,819,915 | 295.41M |
| 197 | OGN | Organon & Co. | 3.55B | -0.29% | 3,824,238 | 6.16B |
| 198 | NHC | National HealthCare Corporation | 3.53B | 1.89% | 72,354 | 1.53B |
| 199 | GPCR | Structure Therapeutics Inc. | 3.49B | -3.31% | 655,405 | - |
| 200 | TLX | Telix Pharmaceuticals Limited | 3.48B | -2.76% | 83,019 | 803.79M |
| 201 | NAMS | NewAmsterdam Pharma Company N.V. | 3.47B | -2.98% | 1,093,346 | 22.57M |
| 202 | ARQT | Arcutis Biotherapeutics, Inc. | 3.42B | 0.07% | 819,219 | 415.62M |
| 203 | OPCH | Option Care Health, Inc. | 3.40B | 2.75% | 1,571,046 | 5.67B |
| 204 | IDYA | IDEAYA Biosciences, Inc. | 3.37B | -2.29% | 901,709 | 225.27M |
| 205 | ITGR | Integer Holdings Corporation | 3.35B | 1.15% | 276,818 | 1.86B |
| 206 | PRVA | Privia Health Group, Inc. | 3.21B | 2.12% | 909,802 | 2.25B |
| 207 | ACHC | Acadia Healthcare Company, Inc. | 3.17B | 1.47% | 2,263,536 | 3.37B |
| 208 | WRBY | Warby Parker Inc. | 3.01B | 1.03% | 2,164,103 | 890.57M |
| 209 | MBX | MBX Biosciences, Inc. | 2.95B | -2.47% | 500,908 | - |
| 210 | GRAL | GRAIL, Inc. | 2.91B | -3.58% | 350,425 | 156.12M |
| 211 | RGC | Regencell Bioscience Holdings Limited | 2.83B | 1.78% | 162,163 | - |
| 212 | IRON | Disc Medicine, Inc. | 2.83B | -2.29% | 403,318 | - |
| 213 | CLDX | Celldex Therapeutics, Inc. | 2.77B | -0.40% | 639,219 | 865.00K |
| 214 | ESTA | Establishment Labs Holdings Inc. | 2.72B | 1.34% | 208,066 | 229.58M |
| 215 | SUPN | Supernus Pharmaceuticals, Inc. | 2.68B | -2.10% | 521,443 | 776.83M |
| 216 | QURE | uniQure N.V. | 2.68B | -1.17% | 1,345,746 | 18.09M |
| 217 | ATAI | AtaiBeckley Inc. | 2.66B | 0.14% | 6,965,932 | 3.49M |
| 218 | RARE | Ultragenyx Pharmaceutical Inc. | 2.64B | -0.44% | 1,495,613 | 670.00M |
| 219 | XRAY | DENTSPLY SIRONA Inc. | 2.59B | 1.65% | 3,955,049 | 3.68B |
| 220 | KOD | Kodiak Sciences Inc. | 2.59B | 0.95% | 512,890 | - |
| 221 | GRDN | Guardian Pharmacy Services, Inc. | 2.56B | 2.56% | 251,604 | 1.46B |
| 222 | VERA | Vera Therapeutics, Inc. | 2.54B | -2.48% | 785,912 | - |
| 223 | TARS | Tarsus Pharmaceuticals, Inc. | 2.52B | 0.14% | 444,355 | 535.08M |
| 224 | IMNM | Immunome, Inc. | 2.52B | 0.91% | 615,225 | 4.02M |
| 225 | BEAM | Beam Therapeutics Inc. | 2.50B | -3.13% | 1,810,181 | 164.01M |
| 226 | TMDX | TransMedics Group, Inc. | 2.50B | 1.59% | 1,138,798 | 635.89M |
| 227 | TRVI | Trevi Therapeutics, Inc. | 2.49B | 2.07% | 1,652,093 | - |
| 228 | PGNY | Progyny, Inc. | 2.44B | 1.60% | 644,559 | 1.29B |
| 229 | NRIX | Nurix Therapeutics, Inc. | 2.43B | -1.52% | 833,253 | 36.77M |
| 230 | NKTR | Nektar Therapeutics | 2.39B | 1.97% | 835,967 | 55.63M |
| 231 | PHVS | Pharvaris N.V. | 2.39B | 2.74% | 255,706 | - |
| 232 | BCRX | BioCryst Pharmaceuticals, Inc. | 2.37B | -0.43% | 1,851,785 | 885.72M |
| 233 | MLYS | Mineralys Therapeutics, Inc. | 2.35B | -1.07% | 648,860 | - |
| 234 | PBH | Prestige Consumer Healthcare Inc. | 2.35B | 1.47% | 350,481 | 1.09B |
| 235 | VCEL | Vericel Corporation | 2.30B | - | 360,247 | 292.09M |
| 236 | KLRA | Kailera Therapeutics, Inc. | 2.29B | 1.67% | 672,853 | - |
| 237 | CLOV | Clover Health Investments, Corp. | 2.28B | -5.05% | 2,958,595 | 2.21B |
| 238 | NUVB | Nuvation Bio Inc. | 2.24B | -1.08% | 6,140,390 | 143.05M |
| 239 | IOVA | Iovance Biotherapeutics, Inc. | 2.23B | -2.73% | 9,431,084 | 285.61M |
| 240 | SLS | SELLAS Life Sciences Group, Inc. | 2.23B | -8.27% | 6,728,973 | - |
| 241 | COAG | Hemab Therapeutics Holdings, Inc. | 2.21B | 3.23% | 779,646 | - |
| 242 | LMAT | LeMaitre Vascular, Inc. | 2.18B | -1.95% | 349,463 | 256.28M |
| 243 | AGIO | Agios Pharmaceuticals, Inc. | 2.16B | 0.22% | 890,109 | 66.05M |
| 244 | ZLAB | Zai Lab Limited | 2.16B | -2.34% | 477,785 | 453.28M |
| 245 | BHVN | Biohaven Ltd. | 2.16B | -2.25% | 1,718,080 | - |
| 246 | VRDN | Viridian Therapeutics, Inc. | 2.13B | 0.05% | 1,514,008 | 70.92M |
| 247 | MD | Pediatrix Medical Group, Inc. | 2.11B | 2.66% | 533,293 | 1.93B |
| 248 | AXGN | Axogen, Inc. | 2.10B | -0.60% | 750,546 | 238.11M |
| 249 | ADUS | Addus HomeCare Corporation | 2.09B | 2.35% | 175,891 | 1.45B |
| 250 | PLSE | Pulse Biosciences, Inc. | 2.09B | -2.48% | 367,455 | 751.00K |
| 251 | HTFL | HeartFlow, Inc. | 2.08B | -1.99% | 888,211 | 191.42M |
| 252 | SION | Sionna Therapeutics, Inc. | 2.06B | 3.72% | 654,931 | - |
| 253 | AVAH | Aveanna Healthcare Holdings Inc. | 2.06B | 4.07% | 2,955,578 | 2.52B |
| 254 | NVCR | NovoCure Limited | 2.06B | -11.71% | 3,879,987 | 699.19M |
| 255 | AMLX | Amylyx Pharmaceuticals, Inc. | 2.05B | 4.66% | 1,634,706 | -665.00K |
| 256 | NEOG | Neogen Corporation | 2.05B | -2.19% | 1,190,281 | 870.56M |
| 257 | HRMY | Harmony Biosciences Holdings, Inc. | 2.04B | -1.34% | 585,338 | 899.11M |
| 258 | SGRY | Surgery Partners, Inc. | 2.04B | 3.35% | 4,116,820 | 3.34B |
| 259 | NBTX | Nanobiotix S.A. | 2.02B | 0.38% | 103,746 | 38.27M |
| 260 | MESO | Mesoblast Limited | 2.02B | -4.79% | 188,256 | 65.38M |
| 261 | URGN | UroGen Pharma Ltd. | 2.00B | -3.60% | 421,251 | 140.49M |
| 262 | PVLA | Palvella Therapeutics, Inc. | 1.98B | -3.63% | 184,281 | - |
| 263 | AUPH | Aurinia Pharmaceuticals Inc. | 1.97B | 0.72% | 792,970 | 298.30M |
| 264 | SNDA | Sonida Senior Living, Inc. | 1.95B | 3.78% | 327,460 | 367.34M |
| 265 | RAPP | Rapport Therapeutics, Inc. | 1.95B | -1.69% | 269,624 | 20.00M |
| 266 | PGEN | Precigen, Inc. | 1.93B | -2.53% | 2,866,849 | 31.60M |
| 267 | GLUE | Monte Rosa Therapeutics, Inc. | 1.92B | -1.09% | 870,562 | 42.95M |
| 268 | CDNA | CareDx, Inc. | 1.92B | -1.25% | 481,185 | 412.82M |
| 269 | ZBIO | Zenas BioPharma, Inc. | 1.92B | -1.94% | 558,949 | 10.00M |
| 270 | ADMA | ADMA Biologics, Inc. | 1.92B | -1.19% | 2,341,122 | 509.86M |
| 271 | HCM | HUTCHMED (China) Limited | 1.90B | 0.46% | 50,650 | 548.51M |
| 272 | GHRS | GH Research PLC | 1.87B | -1.27% | 163,862 | - |
| 273 | OMCL | Omnicell, Inc. | 1.86B | 2.86% | 567,478 | 1.23B |
| 274 | OCUL | Ocular Therapeutix, Inc. | 1.86B | -1.33% | 1,166,170 | 52.04M |
| 275 | KARD | Kardigan, Inc. | 1.85B | -4.29% | 157,632 | - |
| 276 | FTRE | Fortrea Holdings Inc. | 1.85B | 0.10% | 1,343,363 | 2.71B |
| 277 | SNDX | Syndax Pharmaceuticals, Inc. | 1.84B | -1.89% | 1,229,045 | 217.17M |
| 278 | LKFT | Lakefront Biotherapeutics NV | 1.84B | -1.00% | 167,205 | 1.20B |
| 279 | UFPT | UFP Technologies, Inc. | 1.84B | 0.42% | 205,001 | 608.85M |
| 280 | STOK | Stoke Therapeutics, Inc. | 1.82B | -1.18% | 441,821 | 32.08M |
| 281 | TYRA | Tyra Biosciences, Inc. | 1.82B | -0.55% | 645,856 | - |
| 282 | ASTH | Astrana Health, Inc. | 1.81B | -1.66% | 441,585 | 3.53B |
| 283 | NEO | NeoGenomics, Inc. | 1.81B | -2.46% | 1,992,831 | 745.97M |
| 284 | ALMR | Alamar Biosciences, Inc. | 1.79B | -0.04% | 246,328 | 87.16M |
| 285 | IMCR | Immunocore Holdings plc | 1.78B | -1.44% | 530,377 | 412.81M |
| 286 | BCAX | Bicara Therapeutics Inc. | 1.78B | -2.56% | 481,656 | - |
| 287 | ATRC | AtriCure, Inc. | 1.77B | 6.18% | 1,655,000 | 569.62M |
| 288 | DMRA | Damora Therapeutics, Inc. | 1.77B | -1.20% | 564,861 | - |
| 289 | TSHA | Taysha Gene Therapies, Inc. | 1.77B | -5.32% | 1,810,583 | 7.47M |
| 290 | WGS | GeneDx Holdings Corp. | 1.75B | -6.75% | 429,408 | 442.68M |
| 291 | MRVI | Maravai LifeSciences Holdings, Inc. | 1.75B | -4.11% | 1,911,374 | 204.73M |
| 292 | BFLY | Butterfly Network, Inc. | 1.72B | -0.60% | 6,019,608 | 102.92M |
| 293 | GENB | Generate Biomedicines, Inc. | 1.72B | -3.11% | 321,443 | 30.30M |
| 294 | AAPG | Ascentage Pharma Group International | 1.66B | -5.38% | 4,578 | 82.08M |
| 295 | MPLT | MapLight Therapeutics, Inc. | 1.66B | 3.78% | 547,342 | - |
| 296 | SRPT | Sarepta Therapeutics, Inc. | 1.66B | -1.26% | 2,138,874 | 2.18B |
| 297 | BHC | Bausch Health Companies Inc. | 1.65B | -0.45% | 1,226,994 | 10.53B |
| 298 | ANIP | ANI Pharmaceuticals, Inc. | 1.65B | -1.12% | 157,948 | 923.71M |
| 299 | ZYME | Zymeworks Inc. | 1.64B | -1.12% | 272,310 | 81.26M |
| 300 | AGL | agilon health, inc. | 1.64B | -2.26% | 247,578 | 5.82B |
| 301 | ABCL | AbCellera Biologics Inc. | 1.62B | -6.35% | 6,271,189 | 79.21M |
| 302 | TRLV | Trulieve Cannabis Corp. | 1.61B | -2.22% | 1,017,787 | 1.17B |
| 303 | ANAB | AnaptysBio, Inc. | 1.60B | -1.38% | 486,834 | 232.39M |
| 304 | TDOC | Teladoc Health, Inc. | 1.58B | 1.27% | 4,347,677 | 2.51B |
| 305 | INVA | Innoviva, Inc. | 1.58B | 1.13% | 550,441 | 420.69M |
| 306 | MLTX | MoonLake Immunotherapeutics | 1.57B | -1.76% | 650,856 | - |
| 307 | RXRX | Recursion Pharmaceuticals, Inc. | 1.57B | -1.66% | 16,530,380 | 66.41M |
| 308 | INNV | InnovAge Holding Corp. | 1.57B | 3.31% | 172,529 | 949.17M |
| 309 | HCSG | Healthcare Services Group, Inc. | 1.56B | 1.40% | 929,958 | 1.86B |
| 310 | ENOV | Enovis Corporation | 1.56B | 3.72% | 850,975 | 2.28B |
| 311 | IART | Integra LifeSciences Holdings Corporation | 1.54B | 6.63% | 901,081 | 1.64B |
| 312 | MAZE | Maze Therapeutics, Inc. | 1.53B | -0.04% | 166,025 | 20.00M |
| 313 | ARDT | Ardent Health, Inc. | 1.53B | 2.11% | 957,160 | 6.43B |
| 314 | CMPS | COMPASS Pathways plc | 1.52B | -3.84% | 3,627,125 | - |
| 315 | XERS | Xeris Biopharma Holdings, Inc. | 1.51B | -1.07% | 1,175,241 | 314.85M |
| 316 | NTLA | Intellia Therapeutics, Inc. | 1.50B | -3.33% | 3,462,561 | 66.09M |
| 317 | SEPN | Septerna, Inc. | 1.49B | -1.11% | 242,034 | 72.26M |
| 318 | AVBP | ArriVent BioPharma, Inc. | 1.48B | 0.60% | 474,964 | - |
| 319 | VIR | Vir Biotechnology, Inc. | 1.47B | -6.96% | 2,149,544 | 65.50M |
| 320 | BLFS | BioLife Solutions, Inc. | 1.46B | -2.57% | 2,610,190 | 101.66M |
| 321 | XNCR | Xencor, Inc. | 1.44B | -0.46% | 632,668 | 97.36M |
| 322 | HROW | Harrow, Inc. | 1.43B | -8.19% | 888,577 | 268.68M |
| 323 | AHCO | AdaptHealth Corp. | 1.43B | 2.77% | 821,487 | 3.29B |
| 324 | PNTG | The Pennant Group, Inc. | 1.43B | 3.39% | 175,684 | 1.02B |
| 325 | INSP | Inspire Medical Systems, Inc. | 1.42B | -3.19% | 658,379 | 915.25M |
| 326 | SVRA | Savara Inc. | 1.40B | -4.17% | 1,548,718 | - |
| 327 | PRGO | Perrigo Company plc | 1.40B | -0.10% | 2,545,009 | 4.18B |
| 328 | PAHC | Phibro Animal Health Corporation | 1.38B | -0.01% | 137,275 | 1.50B |
| 329 | FBRX | Forte Biosciences, Inc. | 1.34B | -8.24% | 574,456 | - |
| 330 | AKTS | Aktis Oncology, Inc. | 1.32B | -0.50% | 193,793 | 8.28M |
| 331 | AHG | Akso Health Group | 1.29B | 2.72% | 5,418 | 13.83M |
| 332 | CNMD | CONMED Corporation | 1.29B | 3.42% | 434,866 | 1.37B |
| 333 | ABSI | Absci Corporation | 1.28B | -6.32% | 2,594,613 | 1.84M |
| 334 | MNKD | MannKind Corporation | 1.28B | 6.17% | 9,444,208 | 360.78M |
| 335 | AMN | AMN Healthcare Services, Inc. | 1.28B | -0.54% | 498,588 | 3.42B |
| 336 | ATEC | Alphatec Holdings, Inc. | 1.27B | 0.61% | 1,457,060 | 787.08M |
| 337 | AZTA | Azenta, Inc. | 1.26B | -3.29% | 698,114 | 596.48M |
| 338 | ORIC | ORIC Pharmaceuticals, Inc. | 1.25B | 11.11% | 3,613,159 | - |
| 339 | ARDX | Ardelyx, Inc. | 1.24B | -1.95% | 1,719,518 | 427.68M |
| 340 | IMTX | Immatics N.V. | 1.24B | -2.26% | 290,487 | 43.00M |
| 341 | TRAX | First Tracks Biotherapeutics, Inc. | 1.24B | -5.63% | 495,335 | - |
| 342 | AVLN | Avalyn Pharma Inc. | 1.24B | -5.99% | 139,579 | - |
| 343 | KMTS | Kestra Medical Technologies, Ltd. | 1.23B | -2.36% | 176,375 | 95.13M |
| 344 | PSNL | Personalis, Inc. | 1.23B | -3.60% | 2,900,374 | 64.52M |
| 345 | AORT | Artivion, Inc. | 1.23B | 1.12% | 370,209 | 458.69M |
| 346 | NVAX | Novavax, Inc. | 1.23B | -4.73% | 3,178,301 | 596.34M |
| 347 | OMDA | Omada Health, Inc. | 1.22B | -3.16% | 1,224,893 | 283.30M |
| 348 | IRMD | IRADIMED CORPORATION | 1.21B | 0.67% | 79,664 | 86.28M |
| 349 | INBX | Inhibrx Biosciences, Inc. | 1.20B | -4.06% | 164,938 | 1.30M |
| 350 | JBIO | Jade Biosciences, Inc. | 1.19B | 2.34% | 684,561 | - |
| 351 | TNDM | Tandem Diabetes Care, Inc. | 1.17B | 1.30% | 1,147,466 | 1.03B |
| 352 | AVNS | Avanos Medical, Inc. | 1.17B | 0.04% | 2,075,760 | 715.90M |
| 353 | CERT | Certara, Inc. | 1.17B | 5.63% | 5,624,183 | 419.75M |
| 354 | ETON | Eton Pharmaceuticals, Inc. | 1.17B | -3.51% | 385,469 | 86.93M |
| 355 | STAA | STAAR Surgical Company | 1.16B | -3.35% | 488,823 | 290.38M |
| 356 | COLL | Collegium Pharmaceutical, Inc. | 1.14B | -1.10% | 254,084 | 796.33M |
| 357 | CAPR | Capricor Therapeutics, Inc. | 1.14B | -0.66% | 2,469,809 | 11.13M |
| 358 | USPH | U.S. Physical Therapy, Inc. | 1.14B | 2.21% | 178,650 | 787.69M |
| 359 | SPTX | Seaport Therapeutics, Inc. | 1.13B | -3.83% | 53,530 | - |
| 360 | DRTS | Alpha Tau Medical Ltd. | 1.13B | -5.59% | 364,525 | - |
| 361 | SDGR | Schrödinger, Inc. | 1.12B | -1.06% | 981,722 | 254.91M |
| 362 | WVE | Wave Life Sciences Ltd. | 1.12B | 0.52% | 2,067,115 | 71.80M |
| 363 | CRVS | Corvus Pharmaceuticals, Inc. | 1.10B | -4.46% | 955,748 | - |
| 364 | QDEL | QuidelOrtho Corporation | 1.09B | -3.20% | 913,040 | 2.66B |
| 365 | ALVO | Alvotech | 1.09B | -3.77% | 588,655 | 562.04M |
| 366 | MGTX | MeiraGTx Holdings plc | 1.09B | -2.73% | 497,312 | 79.76M |
| 367 | CRON | Cronos Group Inc. | 1.05B | 2.55% | 1,224,372 | 159.54M |
| 368 | CGEM | Cullinan Therapeutics, Inc. | 1.05B | -1.04% | 316,644 | - |
| 369 | LMRI | Lumexa Imaging Holdings, Inc. | 1.05B | 1.67% | 242,224 | 1.03B |
| 370 | VOR | Vor Biopharma Inc. | 1.04B | 1.48% | 638,804 | - |
| 371 | ANRO | Alto Neuroscience, Inc. | 1.04B | -0.26% | 295,573 | - |
| 372 | IVA | Inventiva S.A. | 1.03B | -1.11% | 667,373 | 7.94M |
| 373 | EYPT | EyePoint, Inc. | 1.02B | -2.25% | 1,468,693 | 7.61M |
| 374 | OLMA | Olema Pharmaceuticals, Inc. | 1.02B | -0.34% | 806,830 | - |
| 375 | PCRX | Pacira BioSciences, Inc. | 1.02B | -0.19% | 425,446 | 734.86M |
| 376 | LXRX | Lexicon Pharmaceuticals, Inc. | 1.02B | -0.43% | 1,681,849 | 69.64M |
| 377 | GMRS | GMR Solutions Inc. | 1.01B | 2.53% | 222,041 | 5.83B |
| 378 | LBRX | LB Pharmaceuticals Inc | 1.00B | 1.13% | 333,822 | - |
| 379 | NUTX | Nutex Health Inc. | 1.00B | -5.01% | 132,674 | 879.95M |
| 380 | GDRX | GoodRx Holdings, Inc. | 1.00B | 3.14% | 530,413 | 787.89M |
| 381 | BVS | Bioventus Inc. | 985.71M | 2.79% | 472,857 | 576.30M |
| 382 | AVTX | Avalo Therapeutics, Inc. | 975.53M | 3.83% | 800,235 | 59.00K |
| 383 | BIOA | BioAge Labs, Inc. | 967.74M | -0.59% | 1,031,017 | 10.32M |
| 384 | SANA | Sana Biotechnology, Inc. | 953.68M | -0.93% | 2,381,132 | - |
| 385 | PRCT | PROCEPT BioRobotics Corporation | 949.98M | -4.90% | 1,885,486 | 322.02M |
| 386 | JANX | Janux Therapeutics, Inc. | 934.89M | -2.48% | 550,012 | 13.73M |
| 387 | KURA | Kura Oncology, Inc. | 922.37M | -0.57% | 1,137,952 | 71.64M |
| 388 | OPK | OPKO Health, Inc. | 921.21M | 4.27% | 2,549,094 | 581.12M |
| 389 | GERN | Geron Corporation | 910.96M | -2.07% | 3,292,710 | 196.12M |
| 390 | PHAT | Phathom Pharmaceuticals, Inc. | 908.68M | -1.38% | 936,449 | 204.89M |
| 391 | ODTX | Odyssey Therapeutics, Inc. | 893.40M | 5.60% | 161,438 | 1.06M |
| 392 | PHAR | Pharming Group N.V. | 886.13M | -4.21% | 5,373 | 369.49M |
| 393 | TBPH | Theravance Biopharma, Inc. | 873.82M | - | 652,200 | 109.78M |
| 394 | TALK | Talkspace, Inc. | 872.74M | - | 1,118,950 | 238.37M |
| 395 | INMD | InMode Ltd. | 871.98M | 0.53% | 419,196 | 374.64M |
| 396 | ABUS | Arbutus Biopharma Corporation | 865.22M | -2.01% | 876,893 | 191.45M |
| 397 | ANNX | Annexon, Inc. | 855.26M | -1.51% | 2,733,391 | - |
| 398 | GLAS | Glass House Brands Inc. | 852.45M | -0.20% | 892,266 | 177.68M |
| 399 | AMPH | Amphastar Pharmaceuticals, Inc. | 825.42M | -0.79% | 445,582 | 720.53M |
| 400 | REPL | Replimune Group, Inc. | 814.45M | -7.27% | 3,267,434 | - |
| 401 | DBVT | DBV Technologies S.A. | 801.87M | -1.66% | 190,911 | 5.04M |
| 402 | HSTM | HealthStream, Inc. | 792.75M | 2.82% | 176,543 | 311.78M |
| 403 | AVR | Anteris Technologies Global Corp. | 792.31M | -0.73% | 503,454 | 1.85M |
| 404 | AURA | Aura Biosciences, Inc. | 777.61M | -2.08% | 325,828 | - |
| 405 | SLDB | Solid Biosciences Inc. | 770.86M | -1.88% | 1,088,345 | - |
| 406 | CSTL | Castle Biosciences, Inc. | 748.69M | -3.12% | 408,968 | 339.92M |
| 407 | TENX | Tenax Therapeutics, Inc. | 742.36M | -0.75% | 1,155,071 | - |
| 408 | SIBN | SI-BONE, Inc. | 737.09M | 0.91% | 381,073 | 206.22M |
| 409 | MNPR | Monopar Therapeutics Inc. | 735.99M | 3.95% | 229,795 | - |
| 410 | DSGN | Design Therapeutics, Inc. | 735.74M | 1.29% | 417,044 | - |
| 411 | CLYM | Climb Bio, Inc. | 735.23M | 0.63% | 665,913 | - |
| 412 | ACRS | Aclaris Therapeutics, Inc. | 730.44M | -4.56% | 760,669 | 8.37M |
| 413 | FTH | Faeth Therapeutics, Inc. | 729.28M | 1.91% | 129,147 | - |
| 414 | OMER | Omeros Corporation | 708.55M | -4.77% | 799,038 | 9.89M |
| 415 | BBOT | BridgeBio Oncology Therapeutics, Inc. | 706.54M | 1.15% | 186,153 | - |
| 416 | BBNX | Beta Bionics, Inc. | 706.30M | -1.74% | 558,666 | 110.24M |
| 417 | CTMX | CytomX Therapeutics, Inc. | 705.36M | -2.70% | 1,519,806 | 35.54M |
| 418 | CADL | Candel Therapeutics, Inc. | 700.46M | -3.04% | 1,011,915 | - |
| 419 | EVO | Evotec SE | 699.02M | -2.02% | 33,589 | 859.03M |
| 420 | DRUG | Bright Minds Biosciences Inc. | 697.64M | 0.06% | 345,921 | - |
| 421 | SSII | SS Innovations International, Inc. | 695.46M | -2.66% | 144,615 | 48.47M |
| 422 | NGNE | Neurogene Inc. | 695.45M | -1.88% | 161,731 | 925.00K |
| 423 | SGP | SpyGlass Pharma, Inc. | 685.05M | -1.87% | 103,814 | - |
| 424 | RIGL | Rigel Pharmaceuticals, Inc. | 679.77M | -0.22% | 485,297 | 299.77M |
| 425 | CBIO | Crescent Biopharma, Inc. | 673.58M | -4.29% | 272,863 | 11.88M |
| 426 | OCS | Oculis Holding AG | 672.12M | -2.71% | 375,459 | 1.40M |
| 427 | GYRE | Gyre Therapeutics, Inc. | 662.24M | -1.16% | 33,768 | 117.05M |
| 428 | BWAY | BrainsWay Ltd. | 661.66M | -3.27% | 295,054 | 56.22M |
| 429 | CBLL | CeriBell, Inc. | 641.61M | 3.87% | 363,473 | 95.07M |
| 430 | PHR | Phreesia, Inc. | 631.72M | 4.29% | 895,771 | 495.59M |
| 431 | ACHV | Achieve Life Sciences, Inc. | 626.22M | -1.13% | 926,995 | - |
| 432 | MDXG | MiMedx Group, Inc. | 625.57M | 1.69% | 531,892 | 389.42M |
| 433 | TCMD | Tactile Systems Technology, Inc. | 619.85M | 0.15% | 195,141 | 343.52M |
| 434 | CRMD | CorMedix Inc. | 617.42M | -2.24% | 628,686 | 400.05M |
| 435 | AGMB | AgomAb Therapeutics NV | 616.09M | -3.32% | 59,096 | - |
| 436 | IRWD | Ironwood Pharmaceuticals, Inc. | 610.72M | -2.11% | 1,109,141 | 361.51M |
| 437 | NVCT | Nuvectis Pharma, Inc. | 608.76M | -4.17% | 248,222 | - |
| 438 | IMMX | Immix Biopharma, Inc. | 606.54M | -3.18% | 2,318,718 | - |
| 439 | ALLO | Allogene Therapeutics, Inc. | 600.57M | -4.40% | 4,874,170 | 22.00K |
| 440 | RGNX | REGENXBIO Inc. | 600.37M | -5.07% | 974,179 | 87.82M |
| 441 | SPRY | ARS Pharmaceuticals, Inc. | 589.86M | -1.00% | 3,484,923 | 98.99M |
| 442 | CERS | Cerus Corporation | 587.08M | 2.09% | 2,510,834 | 216.56M |
| 443 | CTKB | Cytek Biosciences, Inc. | 575.98M | -2.19% | 597,193 | 204.17M |
| 444 | TECX | Tectonic Therapeutic, Inc. | 573.06M | -3.92% | 98,320 | - |
| 445 | STTK | Shattuck Labs, Inc. | 569.74M | 4.80% | 1,466,467 | 1.00M |
| 446 | ZVRA | Zevra Therapeutics, Inc. | 563.07M | -23.92% | 6,940,003 | 122.29M |
| 447 | ANGO | AngioDynamics, Inc. | 561.71M | 1.12% | 332,997 | 320.17M |
| 448 | FLGT | Fulgent Genetics, Inc. | 558.64M | -1.55% | 145,672 | 320.35M |
| 449 | RLMD | Relmada Therapeutics, Inc. | 543.33M | -0.38% | 1,650,486 | - |
| 450 | ALT | Altimmune, Inc. | 538.69M | -2.46% | 1,911,556 | 36.00K |
| 451 | PRME | Prime Medicine, Inc. | 532.82M | -0.67% | 2,377,949 | 4.03M |
| 452 | VSTM | Verastem, Inc. | 531.64M | -2.10% | 2,529,732 | 49.59M |
| 453 | MYGN | Myriad Genetics, Inc. | 529.85M | -1.58% | 867,629 | 829.00M |
| 454 | FDMT | 4D Molecular Therapeutics, Inc. | 526.42M | -2.99% | 682,419 | 88.24M |
| 455 | CTNM | Contineum Therapeutics, Inc. | 525.65M | -2.16% | 122,841 | - |
| 456 | RZLT | Rezolute, Inc. | 521.29M | -6.03% | 1,146,889 | - |
| 457 | SLN | Silence Therapeutics plc | 520.52M | -3.76% | 341,873 | 839.00K |
| 458 | ARVN | Arvinas, Inc. | 518.11M | -1.11% | 385,661 | 89.40M |
| 459 | NPCE | NeuroPace, Inc. | 504.93M | 0.89% | 268,924 | 99.53M |
| 460 | SLBT | SL Science Holding Limited | 504.27M | -1.58% | 286,722 | 3.36M |
| 461 | MCTA | Charming Medical Limited | 504.26M | -0.85% | - | 5.42M |
| 462 | ANL | Adlai Nortye Ltd. | 500.00M | -5.45% | 130,694 | 5.00M |
| 463 | TOI | The Oncology Institute, Inc. | 497.92M | -1.78% | 1,170,229 | 545.76M |
| 464 | ZURA | Zura Bio Limited | 496.84M | -1.13% | 366,090 | - |
| 465 | ASMB | Assembly Biosciences, Inc. | 491.86M | 1.31% | 142,148 | 71.10M |
| 466 | WEAV | Weave Communications, Inc. | 490.92M | 3.52% | 954,875 | 248.72M |
| 467 | ARTV | Artiva Biotherapeutics, Inc. | 487.34M | -0.99% | 567,954 | 251.00K |
| 468 | KIDS | OrthoPediatrics Corp. | 484.68M | 0.80% | 141,648 | 243.30M |
| 469 | EIKN | Eikon Therapeutics, Inc. | 481.83M | -7.48% | 249,012 | - |
| 470 | DNA | Ginkgo Bioworks Holdings, Inc. | 480.79M | -7.19% | 771,156 | 151.40M |
| 471 | SOPH | SOPHiA GENETICS SA | 479.88M | -5.45% | 192,983 | 81.18M |
| 472 | EVH | Evolent Health, Inc. | 474.67M | -9.05% | 5,638,559 | 1.89B |
| 473 | NRC | NRC Health | 474.17M | 1.01% | 45,683 | 138.64M |
| 474 | HELP | Cybin Inc. | 472.32M | -1.42% | 1,230,799 | - |
| 475 | TLRY | Tilray Brands, Inc. | 462.82M | -2.76% | 6,581,126 | 858.28M |
| 476 | AQST | Aquestive Therapeutics, Inc. | 461.72M | -2.39% | 2,881,316 | 50.27M |
| 477 | VREX | Varex Imaging Corporation | 460.24M | 1.87% | 475,575 | 857.50M |
| 478 | PRTA | Prothena Corporation plc | 458.09M | 2.58% | 576,837 | 57.94M |
| 479 | VALN | Valneva SE | 455.82M | - | 6,232 | 180.25M |
| 480 | IKT | Inhibikase Therapeutics, Inc. | 455.33M | - | 2,158,411 | 1.00 |
| 481 | OFIX | Orthofix Medical Inc. | 454.74M | 2.65% | 238,980 | 825.37M |
| 482 | PROK | ProKidney Corp. | 453.09M | -1.32% | 1,716,911 | 889.00K |
| 483 | VMD | Viemed Healthcare, Inc. | 451.22M | 0.86% | 228,679 | 286.57M |
| 484 | KYTX | Kyverna Therapeutics, Inc. | 450.49M | 1.65% | 850,892 | - |
| 485 | CABA | Cabaletta Bio, Inc. | 438.62M | -1.10% | 1,662,347 | - |
| 486 | SGMT | Sagimet Biosciences Inc. | 436.59M | 0.86% | 910,897 | - |
| 487 | SRTA | Strata Critical Medical, Inc. | 436.09M | -0.98% | 1,074,599 | 228.58M |
| 488 | OVID | Ovid Therapeutics Inc. | 434.87M | -2.92% | 984,942 | 7.12M |
| 489 | NNNN | Anbio Biotechnology | 434.52M | 1.64% | 17,007 | 8.65M |
| 490 | CLPT | ClearPoint Neuro, Inc. | 423.45M | -2.55% | 467,354 | 40.61M |
| 491 | SI | Shoulder Innovations, Inc. | 423.27M | 0.54% | 43,491 | 53.89M |
| 492 | PACB | Pacific Biosciences of California, Inc. | 422.42M | -2.86% | 8,063,247 | 160.03M |
| 493 | DCTH | Delcath Systems, Inc. | 421.85M | -1.69% | 301,355 | 90.44M |
| 494 | LRMR | Larimar Therapeutics, Inc. | 417.53M | -0.25% | 1,230,901 | - |
| 495 | OCGN | Ocugen, Inc. | 409.61M | -4.72% | 4,119,147 | 4.47M |
| 496 | EVMN | Evommune, Inc. | 409.17M | 0.35% | 274,130 | 10.00M |
| 497 | KMDA | Kamada Ltd. | 409.11M | 1.44% | 17,807 | 181.68M |
| 498 | PBYI | Puma Biotechnology, Inc. | 406.18M | -0.37% | 205,692 | 227.18M |
| 499 | EDIT | Editas Medicine, Inc. | 399.00M | -4.76% | 1,515,551 | 38.69M |
| 500 | BNTC | Benitec Biopharma Inc. | 394.04M | 0.26% | 161,893 | - |